ArticleFrontiers in medicine2021
Increased INR Values Predict Accelerating Deterioration and High Short-Term Mortality Among Patients Hospitalized With Cirrhosis or Advanced Fibrosis.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 23 citations in OpenAlex.
- Predictors of spontaneous bacterial peritonitis among cirrhotic patients with ascites in Dodoma, Tanzania: a cross-sectional study.Future science OA · 2026Article
- Early Prediction of Hepatic Decompensation in Cirrhosis Using Optimised XGBoost Models at the Initial Outpatient Hepatology Visit.Liver international : official journal of the International Association for the Study of the Liver · 2026Article
- [Impact of key indicator dynamic change on 90-day prognosis for patients with acute-on-chronic liver failure].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Article
- Risk factors for the development of cirrhosis within 1-year in non-cirrhotic patients with HBV- related acute-on-chronic liver failure.Frontiers in medicine · 2026Article
- Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis.Thrombosis and haemostasis · 2025Article
- Predictive machine learning model in intensive care unit patients with acute-on-chronic liver failure and two or more organ failures.Clinical and molecular hepatology · 2025Article
- Vibrio vulnificus Causing Severe Multiorgan Failure in a Patient With Underlying Cirrhosis.Cureus · 2025Article
- Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C.Clinical and molecular hepatology · 2025Article
- A Novel Scoring System for Assessing In-Hospital Mortality Risk in Patients With Liver Cirrhosis.Cureus · 2024Article
- Establishment of a prognostic model for hospitalized cirrhotic patients with infection based on lumbar muscle mass.Heliyon · 2024Article
- Clinical features and prognosis of acute-on-chronic liver failure in patients with recompensated cirrhosis.BMC gastroenterology · 2023Article
- Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline Functions.Frontiers in public health · 2022Article
- Liver Fibrosis is Associated with Clinical Outcomes in Patients with Intracerebral Hemorrhage.Neuropsychiatric disease and treatment · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
43 authors at 20 institutions in 1 country.
Ying WangDepartment of Infectious Disease, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Fuchen DongChinese Chronic Liver Failure Consortium, China.
Shuning SunChinese Chronic Liver Failure Consortium, China.
Xianbo WangChinese Chronic Liver Failure Consortium, China.
Xin ZhengChinese Chronic Liver Failure Consortium, China.
Yan HuangChinese Chronic Liver Failure Consortium, China.
Beiling LiChinese Chronic Liver Failure Consortium, China.
Yanhang GaoChinese Chronic Liver Failure Consortium, China.
Zhiping QianChinese Chronic Liver Failure Consortium, China.
Feng LiuChinese Chronic Liver Failure Consortium, China.
Xiaobo LuChinese Chronic Liver Failure Consortium, China.
Junping LiuChinese Chronic Liver Failure Consortium, China.
Haotang RenChinese Chronic Liver Failure Consortium, China.
Yubao ZhengChinese Chronic Liver Failure Consortium, China.
Huadong YanChinese Chronic Liver Failure Consortium, China.
Guohong DengChinese Chronic Liver Failure Consortium, China.
Liang QiaoChinese Chronic Liver Failure Consortium, China.
Yan ZhangChinese Chronic Liver Failure Consortium, China.
Wenyi GuChinese Chronic Liver Failure Consortium, China.
Xiaomei XiangChinese Chronic Liver Failure Consortium, China.
Yi ZhouChinese Chronic Liver Failure Consortium, China.
Baoyan XuChinese Chronic Liver Failure Consortium, China.
Yixin HouChinese Chronic Liver Failure Consortium, China.
Qun ZhangChinese Chronic Liver Failure Consortium, China.
Yan XiongChinese Chronic Liver Failure Consortium, China.
Congcong ZouChinese Chronic Liver Failure Consortium, China.
Jun ChenChinese Chronic Liver Failure Consortium, China.
Zebing HuangChinese Chronic Liver Failure Consortium, China.
Xiuhua JiangChinese Chronic Liver Failure Consortium, China.
Tingting QiChinese Chronic Liver Failure Consortium, China.
Sen LuoDepartment of Infectious Disease, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Yuanyuan ChenDepartment of Infectious Disease, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Na GaoChinese Chronic Liver Failure Consortium, China.
Chunyan LiuChinese Chronic Liver Failure Consortium, China.
Wei YuanChinese Chronic Liver Failure Consortium, China.
Xue MeiChinese Chronic Liver Failure Consortium, China.
Jing LiChinese Chronic Liver Failure Consortium, China.
Tao LiChinese Chronic Liver Failure Consortium, China.
Rongjiong ZhengChinese Chronic Liver Failure Consortium, China.
Xinyi ZhouChinese Chronic Liver Failure Consortium, China.
Weituo ZhangChinese Chronic Liver Failure Consortium, China.
Hai LiChinese Chronic Liver Failure Consortium, China.
Zhongji MengDepartment of Infectious Disease, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Shanghai Jiao Tong University · CNSouthwest Hospital · CNBeijing Ditan Hospital · CNHubei University of Medicine · CNSecond Hospital of Shandong University · CNShanghai Public Health Clinical Center · CNFirst Hospital of Jilin University · CNNanfang Hospital · CNRenji Hospital · CNUnion Hospital · CNXiangya Hospital Central South University · CNXinjiang Medical University · CNArmy Medical University · CNCentral South University · CNFirst Affiliated Hospital of Xinjiang Medical University · CNHenan Provincial People's Hospital · CNHuazhong University of Science and Technology · CNJilin University · CNNingbo No. 2 Hospital · CNSouthern Medical University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
acute on chronic liver failure (ACLF)advanced fibrosiscirrhosisinternational normalized ratio (INR)short-term prognosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.